Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Cancer Research Highlight: Puma Biotech's Basket Pays Off [Seeking Alpha]

Puma Biotechnology Inc (PBYI) 
Last puma biotechnology inc earnings: 2/20 04:07 pm Check Earnings Report
US:NYSE Investor Relations: pumabiotechnology.com/ir.html
Company Research Source: Seeking Alpha
Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. If you're interested in this service, you can try a free two-week trial today! Puma Biotechnology ( PBYI ) has made its entire game up on the back of one drug, a pan-HER inhibitor called neratinib (branded Nerlynx). It offers a unique proposition from the more commonly used HER2 therapies marketed by Roche ( OTCQX:RHHBY ), such as Herceptin, because it is given as pills. This opens up the possibility of continuous therapy, and we saw this realized with an approval in the extended adjuvant setting of patients with HER2-positive breast cancer last year. Earlier this year, PBYI scored a coup when it was able to reverse the decision by the EMA to not allow its drug to reach market in the EU. Now, neratinib is available Show less Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
PBYI alerts

from News Quantified
Opt-in for
PBYI alerts

from News Quantified